Khiron Life Sciences

(OTC: KHRNF)
Healthcare  |  Drug Manufacturers—Specialty & Generic
0.34 -0.0022 -0.63%
Stock Price | Oct. 22, 2020, 3:24 p.m.
0 Followers
Bid: 0.335
Ask: 0.352
Prev. Close: 0.339655
52 Week Low: 0.285
52 Week High: 0.6463
PE Ratio: 0.0
Dividend Yield: 0.0%

Company Summary

Khiron Life Sciences Corp is the dominant integrated medical cannabis company in Latin America. It has core operations in Latin America, along with activity in North America and Europe, and is licensed in Colombia for the cultivation, production, domestic distribution, and international export of both tetrahydrocannabinol (THC) and cannabidiol (CBD) medical cannabis. The company addresses priority medical conditions such as chronic pain, epilepsy, depression and anxiety in the Latin American market. Its segments include Medical cannabis products, Health services, and Wellbeing products. Its operations in Lati America derives majority of the revenue.

Read more Read less

Recently Viewed Tickers

Premium Changes to the Global Cannabis Stock Index

1 Comments
1 year ago

Premium Changes to the Global Cannabis Stock Index

9 Comments
1 year ago

Premium Toking Tuesday - 2/19/19

3 Comments
1 year ago

Premium Changes to the Global Cannabis Stock Index

4 Comments
1 year ago

Premium Rebalancing the Global Cannabis Stock index

13 Comments
2 years ago